PSMA6 and benign prostatic hyperplasia: However, the association of alpha-1 blocker exposure and RCC risk seen in patients without BPH was still high in male populations, not only in the subgroup with hypertension but also in the one without hypertension (HR, 2.31; 95% CI, 1.40−3.81; P < .001).